A pioneering study conducted by leading researchers at the University of Sheffield has revealed blood types play a role in the development of the nervous system and may cause a higher risk of developing cognitive decline.
The research, carried out in collaboration with the IRCCS San Camillo Hospital Foundation in Venice, shows that people with an ‘O’ blood type have more grey matter in their brain, which helps to protect against diseases such as Alzheimer’s, than those with ‘A’, ‘B’ or ‘AB’ blood types.
See original article: via Your Blood Type May Help Protect You From Cognitive Decline – Neuroscience News
Continue reading “Your Blood Type May Help Protect You From Cognitive Decline”
Alzheimer’s disease causes atrophy of brain tissue. The discovery that lymph vessels near the brain’s surface help remove waste suggests glitches in the lymph system might be involved in Alzheimer’s and a variety of other brain diseases.
Fresh evidence that the body’s immune system interacts directly with the brain could lead to a new understanding of diseases from multiple sclerosis to Alzheimer’s.
A study of human and monkey brains found lymphatic vessels — a key part of the body’s immune system — in a membrane that surrounds the brain and nervous system, a team reported Tuesday in the online journal eLife.
Continue reading “Brain’s Link To Immune System Might Help Explain Alzheimer’s”
Keeping up with Mental Health: Be aware of who and for what you are influenced by. Use this article to help stay positive and focused on your well-being goals.
Our interactions with one another are overall based on a healthy exchange of emotions, ideas and positive social interactions. There are some individuals, however, that have a disruptive influence in our lives. Manipulation may be a factor in a number of mental disorders. Psychological manipulation is a type of social influence that uses deception, underhanded tactics and abuse in order to achieve the interests of the manipulator. it is important to know how to identify manipulation and how to deal with it.
By Eric Perry, PhD-c “You learn a lot about people when they don’t get what they want.” ~Anonymous Like the waves that forcefully crash on the shore and later gracefully retreat, there is an ebb and flow to life. The seasons change and the flowers bloom, only to later wilt. We all give and take […]
Continue reading “How to Spot Psychological Manipulators — MakeItUltra™”
Genetically-engineered moss to the rescue:
A study in Frontiers in Bioengineering and Biotechnology shows that genetically engineered moss can rapidly produce artemisinin at an industrial scale.
via New method for producing malaria drug at large scales — Science & research news | Frontiers | Open-access publisher — By D. Rachael Bishop
For the first time, the malaria treatment artemisinin has been rapidly produced by genetically engineered moss at an industrial scale.
Malaria is proving one of the most challenging human diseases to eradicate. A new method for producing the first choice treatment, artemisinin, offers new hope for stabilizing supplies of this critical anti-malarial drug and combating one of humankind’s most deadly and persistent parasitic diseases.
Continue reading “New method for producing malaria drug at large scales — Science & research news | Frontiers | Open-access publisher”
There is a critical need to rethink standards of evidence and of the reliability of information used to make regulatory decisions, which involves placing greater reliance on data from sources outside traditional clinical studies, according to FDA officials and industry leaders. While the randomized, prospective placebo controlled trial remains at the “top of the pyramid” for reliability of evidence, new tools for collecting data and methodologies for evaluating different forms of information requires FDA to adapt to this new information matrix, said FDA commissioner Scott Gottlieb in keynote remarks at a recent workshop on the Impact of Real World Evidence on Medical Product Development at the National Academy of Sciences, Engineering, and Medicine (NASEM).
Continue reading “FDA Seeks More Informative Clinical Research”